For example, Bretland et al., [264] showed that a 4-week injection of recombinant (r)-irisin (100 μg/kg weekly) significantly decreased the tau phosphorylation load and inflammatory cytokine levels such as TNF-α in the hippocampus of a transgenic rodent model of AD. The gene discussed is MAPT; the disease is Alzheimer disease.